1 results match your criteria: "Center for Vaccine Clinical Trials[Affiliation]"
An open, prospective, randomized study comparing the immunogenicity and safety of two inactivated hepatitis A pediatric vaccines in toddlers, children and adolescents in China.
Pediatr Infect Dis J
February 2013
Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Center for Vaccine Clinical Trials, Nanning Guangxi, China.
Background: Vaccines against hepatitis A provide long-lasting protection in both adults and children. The aim of this study was to demonstrate that the inactivated hepatitis A vaccine AVAXIM 80U Pediatric is safe and not inferior in terms of seroprotection rate to HAVRIX 720 vaccine 1 month after booster vaccination.
Methods: An open, randomized, single-center trial was conducted in China in healthy antihepatitis A virus seronegative individuals from 12 months to 15 years of age.